Results 331 to 340 of about 525,220 (392)
Fluorine-18-Labeled Positron Emission Tomography Probe Targeting Activated p38α: Design, Synthesis, and In Vivo Evaluation in Rodents. [PDF]
Futatsugi M+4 more
europepmc +1 more source
Ultrasensitive detection (LOD=2 pM) of insulin amyloid fibril is achieved using a hemicyanine dye. A unique feature of amyloid induced dissociation of ion‐pair and solute‐solvent hydrogen bonding has been established to play a pivotal role for dual mode detection of amyloid fibrils.
Ayentika Sen+3 more
wiley +1 more source
Differentiating Cerebral Amyloid Angiopathy From Alzheimer's Disease Using Dual Amyloid and Tau Positron Emission Tomography. [PDF]
Tsai HH+9 more
europepmc +1 more source
ABSTRACT Angiosarcoma with malignant effusion is an uncommon yet clinically aggressive presentation, which poses as a diagnostic pitfall with its overlapping cytomorphologic features with metastatic adenocarcinoma. In this article, two cases reported in the literature were reviewed for cytology, immunocytochemistry, and clinical course.
Jamie C. Y. Lam+3 more
wiley +1 more source
Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study. [PDF]
Barton AK+27 more
europepmc +1 more source
Late-Onset Progressive Osseous Heteroplasia: 2 Unrelated Cases and Use of Positron Emission Tomography for Diagnosis. [PDF]
Pham MT+4 more
europepmc +1 more source
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario Thevis+2 more
wiley +1 more source
Positron Emission Tomography Imaging of <i>Acinetobacter baumannii</i> Infection: Comparison of Gallium-68 Labeled Siderophores. [PDF]
Dvorakova Bendova K+8 more
europepmc +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna+4 more
wiley +1 more source